Our Company


LAVIOR is the only company exclusively dedicated to the therapeutic diabetes skin care market. The LAVIOR skincare product line soothes and heals some of the most widespread and challenging skin problems – diabetic ulcers, wounds, burns, eczema/atopic dermatitis, bacterial and fungal infections, skin irritations, cracked skin.

LAVIOR was established by Gilad and Anabelle Savion. Supported by an experienced management team, advisory board and medical professionals, the Savions envisioned and built a comprehensive R&D team to study a new line of skincare products based on the radical healing effects of the Inula AGS RIED species.

Used for centuries to soothe and remedy a variety of skin disorders, the Inula plant is recognized as one of the world’s most powerful and effective healing, anti-inflammatory, anti-bacterial and anti-fungal botanical. It is grown in the Mediterranean and deemed the “King of Medicinal Plants” for generations of physicians, naturalists and healers.


What makes LAVIOR so uniquely different? It is our groundbreaking formulations and our medical understanding of chronic skin disorders that result in breakthrough natural treatments for skin conditions.

All products are FDA OTC and manufactured in a cGMP FDA-compliant manufacturing facility with the capacity to meet growing consumer demand.

They are based on botanicals and OTC active pharmaceutical ingredients. They are developed using the highest quality, pharmaceutical grade ingredients; manufactured and tested to deliver safe, effective, and compliant products. LAVIOR QA team closely monitors and controls each step of product development and manufacturing in our state-of-the-art manufacturing facility.

LAVIOR’s products are backed by over 13 years of research and clinical trials, proven clinical safety and efficacy. They consistently outperform conventional treatments.

Our mission is to improve the quality of life for people with diabetes by providing innovative and natural solutions in preventive care, wound care and skin infection mitigation. This is motivated by both the current lack of effective treatments as well as emerging public concern regarding the health risks associated with products containing synthetic agents.

Our vision is to establish a new standard of care in the wound healing and diabetic skin care market. We will continue to be at the forefront of scientific research and product development so that we can provide natural, plant-based products that ease suffering, speed healing and enhance the quality of life for the hundreds of millions of consumers with diabetes.

US Certifications:

  • FDA OTC – in the USA (NDC Code: 71521)
  • Medical Device in the USA
  • Partner with ADA – Better Choices for Life